Subconjunctival triamcinolone injection for infectious necrotizing scleritis

Ocul Surf. 2022 Oct:26:97-99. doi: 10.1016/j.jtos.2022.07.009. Epub 2022 Aug 9.

Authors

Matthew C Santos¹, Grace L Paley¹, Fouad El Sayyad¹, Eric L Sollenberger¹, Andrew J W Huang²

Affiliations

¹ John F. Hardesty Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, St. Louis, MO, United States.
² John F. Hardesty Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, St. Louis, MO, United States. Electronic address: huangandrew@wustl.edu.

PMID: 35952987
DOI: 10.1016/j.jtos.2022.07.009

No abstract available

Publication types

Letter

MeSH terms

Conjunctiva
Glucocorticoids / therapeutic use
Humans
Injections
Scleritis* / drug therapy
Treatment Outcome
Triamcinolone* / therapeutic use

Substances

Triamcinolone
Glucocorticoids